GLP-1 Therapy Helps Cut Migraine Frequency, Study Finds

Posted June 23, 2025

In a new observational study, patients with migraine given a daily dose of liraglutide, a popular GLP-1 receptor agonist, reported significantly fewer headache days and an improved quality of life.

Health News is provided as a service to J Drugs I site users by HealthDay. J Drugs I nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Get Healthy!

GLP-1 Therapy Helps Cut Migraine Frequency, Study Finds

Health News is provided as a service to J Drugs I site users by HealthDay. J Drugs I nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Copyright © 2025 HealthDay All Rights Reserved.

Tags

Site Navigation

Contact Us

Patient Resources

Get Healthy!

GLP-1 Therapy Helps Cut Migraine Frequency, Study Finds

Health News is provided as a service to J Drugs I site users by HealthDay. J Drugs I nor its employees, agents, or contractors, review, control, or take responsibility for the content of these articles. Please seek medical advice directly from your pharmacist or physician.

Copyright © 2025 HealthDay All Rights Reserved.

Share

Tags

Site Navigation

Contact Us